Midkine Serum Levels in Inflammatory and Non-Inflammatory Dilated Cardiomyopathy
<b>Objectives</b>: This retrospective study examines midkine, an inflammatory cytokine, as a potential serological biomarker to distinguish dilated cardiomyopathy (DCM) and inflammatory dilated cardiomyopathy (DCMi). Identifying such a biomarker is crucial for effective treatment of thes...
Saved in:
| Main Authors: | Ulrich Grabmaier, Bartolo Ferraro, Kristin Lehnert, Astrid Petersmann, Stephan B. Felix, Ludwig T. Weckbach |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/2/504 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coordinated changes in midkine expression and midkine-associated multiomic profile in glioma microenvironment
by: Mieszko Lachota, et al.
Published: (2025-08-01) -
Relationship between serum Midkine and Omentin-1 levels and the severity of sepsis in patients and their prognostic value
by: Lin Gao, et al.
Published: (2024-12-01) -
The inflammatory and nutritional status in patients with dilated cardiomyopathy: Different impact for distinct phenogroups?
by: Tobias Lerchner, et al.
Published: (2025-02-01) -
Serum midkine level and its association with subclinical coronary artery calcification and carotid atherosclerosis in chronic kidney disease
by: Osama Nady Mohamed, et al.
Published: (2025-04-01) -
Midkine (MDK) in cancer and drug resistance: from inflammation to therapy
by: Berna Yıldırım, et al.
Published: (2025-06-01)